A Review on Metal Impurities in Pharmaceuticals

Author:

Patel Ashok B.1,Bundheliya Avadhi R.1,Vyas Amitkumar J.1,Patel Nilesh K.1,Patel Ajay I.1,Lumbhani Arvind N.2

Affiliation:

1. Department of Pharmaceutical Quality Assurance, B.K. Mody Government Pharmacy College, Polytechnic Campus, Near Aji Dam, Bhavnagar Road, Rajkot - 360003 Gujarat, India.

2. Gyanmanjari Pharmacy College, Survey No. 30, Sidsar Road, Near Iscon Eleven, Bhavnagr – 364001 Gujarat, India.

Abstract

Sources of metal impurities can from anywhere in drug product as raw material which may produce using metal catalyst, excipients, process materials, Water or any solvent used, manufacturing equipment, environment, packaging materials. So, it leads to metal impurity in high amount present in final drug product that is why it is important to check the impurity level in final drug product or as well as in process also that it should be present in low or acceptable amount. Any Drug product is not completely pure, some amount of metal impurities are always present in pharmaceutical product may cause various toxicity when it will be administered. Thus it is necessary to check impurity level is present at acceptable amount. The present review gives an account of updated information about metal impurities and reviews the regulatory aspects for such metal impurities in drug substance/drug product. In addition the aim of this article is to discuss the currently used different analytical techniques for detection of metals from drug product like spectrophotometry, X – Ray florescence spectrometry, AAS, INAA, ICP – AES, ICP – MS, MP – AES, Laser Ablation – ICP – MS etc which is used for quality control of metal impurities in pharmaceuticals.

Publisher

A and V Publications

Reference21 articles.

1. EMA – European Medicines Agency guidelines, “Impurities in New Drug substances Q3A(R2)”, CPMP, ICH, 2006.

2. EMA – European Medicines Agency guidelines, “Impurities in New Drug products Q3B(R2)”, CPMP, ICH, 2006.

3. N. Rama Rao, S. S. Mani Kiran and Prasanthi N. L. Pharmaceutical Impurities: An Overview. Indian Journal of Pharmaceutical Education and Research. 2010; 301 – 310.

4. Maithani M et al. Elemental impurities in pharmaceutical products adding fuel to the fire. Regulatory Toxicology and Pharmacology. 2019.

5. Balaram V. Recent advances in the determination of elemental impurities in pharmaceuticals – Status, challenges and moving frontiers. Trends in Analytical Chemistry. 2016; 83 – 95.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3